Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
here comes that 014 break
blue skies indeed once we pass the 014 high in Aug
https://stockcharts.com/h-sc/ui?s=soan&p=D&yr=0&mn=36&dy=0&id=p00231052056
yeah, i thought it was going to do well also since it was reinstated in 2019, then the move from g2p in april 2020, then the annual list in july, and the low SS it had. totally caught me by surprise when i saw the RS today. next!
1:500 RS on today's daily list... hope this doesn't start spoiling the other g2p plays
https://otce.finra.org/otce/dailyList
yeah, from that form 4, you see he has over 30m shares. It's a good sign that he's buying rather than selling
if $200 doesn't pique your interest, then how about $440 worth? lol Chairman/Pres/CEO also bought according to the 2nd Form 4 filing today
https://www.sec.gov/Archives/edgar/data/1084475/000176031920000118/xslF345X03/primary_doc.xml
new Pres/CEO per today's FL SOS filing
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=CHINATELETECHHOLDING%20P990000283162&aggregateId=domp-p99000028316-2b55ac00-204b-469e-97c1-bcaa3310101a&searchTerm=China%20Teletech%20Holding%2C%20Inc.&listNameOrder=CHINATELETECHHOLDING%20P990000283162
news out. https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-announces-successful-application-of-immcelz-immunotherapy-for-treatment-of-stroke-301193921.html
Creative Medical Technology Holdings Announces Successful Application of ImmCelz® Immunotherapy for Treatment of Stroke
Company Plans to Leverage Existing AmnioStem® Expertise for Novel Approach to Protecting and Regenerating Injured Brains
Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto/Creative Medical Technology Hol)
News provided by
Creative Medical Technology Holdings, Inc.
Dec 16, 2020, 07:45 ET
PHOENIX, Dec. 16, 2020 /PRNewswire/ -- Creative Medical Technology Holdings Inc., (OTC – CELZ) announced today positive preclinical data supporting the utilization of its ImmCelz® cell based immunotherapy for treatment of stroke. In an animal model of ischemia stroke, the middle cerebral artery ligation model, administration of ImmCelz® resulted in 34% reduction in infarct volume, whereas control bone marrow mesenchymal stem cells reduced infarct volume by 21%. Additionally, improvements in functional recovery where observed using the Rotarod test. At 28 days after induction of stroke the animals receiving ImmCelz® had superior running time (92% of non-stroke controls) compared to animals which received bone marrow mesenchymal stem cells (73% of non-stroke control). Animals that received saline had a running time that was 50% of non-stroke controls.
"The regenerative potential of immune cells that have been programmed by stem cells is a fascinating and novel area of research." Said Dr. Amit Patel, coinventor of ImmCelz®, and board member of the Company. "Conceptual advantages of using reprogrammed T cells include higher migratory ability due to smaller size, as well as ability to replicate and potentially form "regenerative memory cells."
"This data, which is covered by our previous filed patents, such as no. 15/987739, Generation of autologous immune modulatory cells for treatment of neurological conditions, demonstrate that immune modulation via this stem cell based method may be a novel and superior way of addressing the $30 billion dollar market for stroke therapeutics1." Said Dr. Thomas Ichim, coinventor of the patent and Chief Scientific Officer of the Company. "The fact that this technology, which has priority back to 2017, is demonstrating such stunning results, motivates us to consider filing an Investigational New Drug Application for use in stroke."
Creative Medical Technology Holdings possesses numerous issued patents in the area of cellular therapy including patent no. 10,842,815 covering use of T regulatory cells for spinal disc regeneration, patent no. 9,598,673 covering stem cell therapy for disc regeneration, patent no. 10,792,310 covering regeneration of ovaries using endothelial progenitor cells and mesenchymal stem cells, patent no. 8,372,797 covering use of stem cells for erectile dysfunction, and patent no. 7,569,385 licensed from the University of California covering a novel stem cell type.
"While stroke historically has been a major area of unmet medical need, the rise in stroke cases , as well as the fact that younger people are increasingly falling victim to stroke, strongly motivates us to accelerate our developmental programs and to continue to explore participation of Big Pharma in this space." Said Timothy Warbington, President and CEO of the Company. "We are eager to replicate the existing experiments start compiling the dossier needed to take ImmCelz® into humans using the Investigational New Drug Application (IND) route through the FDA."
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of urology, neurology and orthopedics and trades on the OTC under the ticker symbol CELZ. For further information about the company, please visit www.creativemedicaltechnology.com.
Forward Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
Timothy Warbington, CEO
CEO@ CreativeMedicalHealth.com
Creativemedicaltechnology.com
www.StemSpine.com
www.Caverstem.com
www.Femcelz.com
1 Stroke Management Market Size Forecasts 2026 | Statistics Report (gminsights.com)
SOURCE Creative Medical Technology Holdings, Inc.
Related Links
http://creativemedicaltechnology.com
XMET sold to Wei Tian per today's 8k https://www.sec.gov/Archives/edgar/data/1819006/000121390020042407/ea131552-8k_xxstream.htm
XMET sold to Wei Tian per today's 8k https://www.sec.gov/Archives/edgar/data/1819006/000121390020042407/ea131552-8k_xxstream.htm
gapping again 0095 premarket. let's see how it trades today
10Q out https://www.sec.gov/Archives/edgar/data/1397795/000121390020040987/f10q1020_borninc.htm
from the filing:
Born, Inc. f/k/a Quture International, inc. is a Nevada corporation, was formed in April 2011 to become an emerging healthcare knowledge solution company created to transform health and healthcare by developing the standard in measuring clinical performance and outcomes. The Company developed medical software with tools and analytics intended to reduce costs while improving clinical performance, outcomes, predictive insight, and evidence-based best clinical processes
.011 premarket already
RS, name change tomorrow https://otce.finra.org/otce/dailyList
if this is as big of a reverse merger as many are expecting, then a 1000:1 reverse split makes perfect sense......... to get on the Nasdaq right away since they have minimum price listing requirements! time will tell if that's the case or not
bong747 Wednesday, 11/25/20 04:09:03 PM
Re: J5150 post# 12678 0
Post #
12679
of 12682
Respectfully, there is nothing positive about a 1000:1 reverse split. They are completely wiping out current common shareholders. You're right, always a risk with these reverse mergers. Unfortunate, QUTR had a lot of promise.
Big thanks to Horst for all of his valuable insight along the way! GLTA
looks like a new owner. anyone good w/ handwriting? that signature doesn't look like it says David Lazar to me though i could be wrong.
.0099 printing pre-market already
You're right. Not the same company. Damn.
https://worlds.io/
It popped up as a news item on my Scanz platform yesterday morning, but didn't include a link, just an article, so I figured it was fake. But since it had decent volume, after market close I decided to Google search it by typing in "Texas A&M World's Inc" and saw a bunch of links with the same type of news I saw on Scanz. I posted the article from Texas A&M's own site and provided the link at the bottom of that post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159638968
no idea
Texas A&M System, Worlds Inc. Collaborate On COVID-19 Breathalyzer
Starting Thursday Aggies can use the artificial intelligence-based detector.
By Mike Reilly, Texas A&M University System Communications November 19, 2020
a student blows into a straw
A person uses a disposable straw at the kiosk to blow into a copper inlet. Test results can be sent to a smartphone in less than a minute.
The Texas A&M University System
The simple act of blowing through a straw could soon come to symbolize a breathtaking leap forward in the COVID-19 fight – and in combating other public health threats, including pathogens that could cause future pandemics.
That simple exhaled breath is key to a new device that uses artificial intelligence (AI) to detect whether individuals should be tested for COVID-19. The sophisticated breathalyzer is being developed and tested through a collaboration among a Dallas-based company, Worlds Inc., the U.S. Air Force and The Texas A&M University System.
Called Worlds Protect, the device takes the form of a kiosk where a person uses a disposable straw to blow into a copper inlet. In less than a minute, test results can be sent to the person’s smartphone.
Worlds Inc. co-founders Dave Copps and Chris Rohde envision Worlds Protect kiosks being placed outside of factories, schools, military bases — anywhere large groups of people need to be screened for COVID-19 or other infectious diseases.
“People can walk up and, literally, just breathe into the device,” said Rohde, president of Worlds Inc. “It’s completely noninvasive. There’s no amount of touching. And you quickly get a result. You get a yay or nay.”
The Texas A&M System has invested $1 million in the project’s development. It is assisting Worlds Inc. with engineering and design, prototype building and the mapping of a commercial manufacturing process. Five prototypes will be tried out this fall on the Texas A&M campus.
“Getting tech innovations to market is one of our sweet spots,” said John Sharp, chancellor of The Texas A&M System. “This breakthrough could have lasting impact on global public health.”
One of the prototypes was set up Thursday on the Texas A&M campus to test students and others. Aggies will be tested using both Worlds Protect and polymerase chain reaction (PCR) tests. Results will be compared to test the accuracy of Worlds Protect and refine its system.
More than 800 individuals have been tested with Worlds Protect already at Wright-Patterson Air Force Base in Ohio and Brigham Young University (BYU). Results so far suggest that the accuracy of Worlds Protect is comparable to PCR tests, which are considered the best type of test available for diagnosing COVID-19.
man standing next to kiosk
Inside the Worlds Protect kiosk, a person’s breath is examined for the specific volatile organic compounds generated when someone is fighting the virus.
The Texas A&M University System
“By applying AI, we are able to achieve a high level of accuracy and improve every day as more results are analyzed,” said Copps, CEO of Worlds Inc. “We are using PCR tests as our yardstick to see and understand our progress.”
Copps and Rohde are working with the Food and Drug Administration to obtain Emergency Use Authorization, that eventually could allow Worlds Protect to become an alternative to PCR tests.
Texas A&M System experts are involved from the Texas A&M College of Engineering, the Texas A&M Engineering Experiment Station and the SecureAmerica Institute, an organization headquartered on the RELLIS Campus that assists with high-tech manufacturing.
Rob Gorham, executive director of SecureAmerica, said the Texas A&M System specializes in helping businesses like Worlds Inc. get through the so-called “valley of death” between an invention and commercial viability.
“There’s a lot of work that has to happen,” Gorham said. “You have to think about standards. You have to actually be able to rapidly and with agility circulate your design as well as think through all of the different supply-chain requirements.”
Inside the Worlds Protect kiosk, a person’s breath is examined for the specific volatile organic compounds that are generated by the body when someone is fighting the virus. The test is done with advanced mass spectrometry technology, a chemical analysis made smarter by AI. Worlds Inc. uses AI software to map the chemical code of a body reacting to the infection.
The copper inlet and other key interior elements are heated between each breath to clean and sanitize the device so one individual test does not contaminate another individual test.
Guido Verbeck, a doctoral graduate of Texas A&M, has developed the device’s key technology.
Verbeck, a University of North Texas chemistry professor, has worked with Worlds Inc. software engineers since March. He is a widely known expert on innovative uses of mass spectrometry. His peer-reviewed research on using mass spectrometry to detect COVID-19 was accepted and published recently by the Royal Society of Chemistry.
David Staack, associate professor of mechanical engineering at Texas A&M, has partnered with Worlds Inc. on the development of the breath-capture system for the device. The system controls the variables in how people breathe so that the chemical compounds related to COVID-19 are more easily identified by the mass spectrometry technology.
SecureAmerica is building additional Worlds Protect prototypes for demonstration at U.S Air Force bases and other Department of Defense locations, including Lackland Air Force Base in San Antonio, where the devices could help screen up to 900 airmen weekly who arrive for basic training.
Col. Charles Bris-Bois, leader of the Air Force Disruptive Technology Team at the Pentagon, will coordinate the screening of the airmen in Texas. He also helped arrange the device’s initial testing in Ohio and screening now underway at BYU.
Copps said additional device testing locations within Texas are also being discussed.
Worlds Protect software also could be engineered to detect other health problems, including future pandemics and bioterrorism threats.
“It is exciting for Texas A&M experts to be part of a project with so much potential,” Gorham said. “We could be saving people’s lives, and allow the economy to come back because there’s a way to detect COVID-19 rapidly. It means the world — literally.”
Media contact: Mike Reilly, 979-458-6425 or 512-289-2782, mreilly@tamus.edu
https://today.tamu.edu/2020/11/19/texas-am-system-worlds-inc-collaborate-on-covid-19-breathalyzer/
ENKS about to run. 075 ask wall broken. 079 up
EVUS 0017, up 41%. if 17 breaks, it'll run up quick
0015, up 25%... feels like another run coming
AAWC merger doc finally available. just like it was mentioned, it's been merged into a DE corp of the same name.
https://www.sos.state.co.us/biz/ViewImage.do?masterFileId=20011181716&fileId=20201960781
name change on daily list
https://otce.finra.org/otce/dailyList
changing to Hempstract Inc per today's daily list
https://otce.finra.org/otce/dailyList
15-15D filed today by Rhonda
https://www.otcmarkets.com/filing/html?id=14484928&guid=ZTOeUKi_MSa1Lth
Seems like she's getting things started.
same here. i've been in some of her other plays. some up, some down. i think this one has potential, so i'll just leave it on the sidelines for now and wait for some sort of update while i monitor other runners
officially reinstated just now. Rhonda Keaveney now CEO
dilution may be done. Form D just out:
13. Offering and Sales Amounts
Total Offering Amount $205,000
Total Amount Sold $205,000
Total Remaining to be Sold $0
http://archive.fast-edgar.com/20201019/A82ZM22CZ222B2Z2222K22YZIKG9ZS727522/
we should see a reversal back up imo
ALYI Announces Major Multiparty Agreement
October 16 2020 - 09:23AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Dallas, TX -- October 16, 2020 -- InvestorsHub NewsWire -- Alternet Systems, Inc. (USOTC: ALYI) today announced the completion of a multiparty major milestone agreement anticipated to substantially move the company forward toward realizing its electric mobility ecosystem vision.
The milestone multiparty agreement with participants from three continents was completed yesterday representing a major step toward realizing the ultimate annual electric auto race event central to ALYI’s electric mobility ecosystem.
The specifics on the participants and the details of the agreement remains confidential, though in conjunction with this latest advancement, a press release revealing the magnitude of the agreement and ongoing developments is in the works.
Background:
ALYI has initiated its electric mobility focus first in Sub-Saharan Africa where per capita transportation infrastructure is substantially under resourced. The prevailing low per capita transportation infrastructure is ideal for technology leapfrog opportunities.
Instead of designing specific future products in an isolated lab, ALYI has designed a process to bring a community of stakeholders together with ALYI's own design team to collectively contribute to the future of electric mobility in Sub-Saharan Africa and beyond.
To motivate and inspire collaboration in a rational electric mobility evolutionary process, ALYI has architected an annual electric mobility symposium and conference around an electric auto race as an anchor event.
For more information and to stay up to date on ALYI’s latest developments, please visit www.alternetsystemsinc.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Alternet Systems, Inc. Contact:
Randell Torno
info@lithiumip.com
+1-800-713-0297
https://ih.advfn.com/stock-market/USOTC/alternet-systems-pk-ALYI/stock-news/83476413/alyi-announces-major-multiparty-agreement
Thursday, October 15 2020 3:10 PM, EST MAXX Sports TV Goes Public PR Newswire "Press Releases US - English"
HOUSTON , Oct. 15, 2020 /PRNewswire/ -- MAXX Sports TV, Inc. an Oklahoma corporation, completed a merger into 33 year old Arizona public company, Reconditioned Systems, Inc. on July 1, 2020 , with the merger receiving FINRA approval on October 1, 2020 .On its first day of trading on the OTC Markets under the new Ticker, AMXX, Maxx Sports TV common shares traded at $3.70 per share.
Maxx Sports TV intends to file a Registration Statement with the US Securities and Exchange Commission and will apply to Up-List to NASDAQ during the summer of 2021.
Maxx Sports TV's mission is to become the largest US Sports and eSports broadcaster measured by the volume of games streamed live each year; and is committed to facilitating 100% time and device shifting, enabling Users to determine the time, place and how the Maxx Sports TV video & audio content is consumed.
By using Maxx Sports TV's proprietary low-cost high-quality multi-camera interactive video technology, it will bring audio and print media content to life, creating "audio you can see."Maxx Sports TV lowers the cost of multi-camera broadcast to $500 per game, while ensuring that game production quality is as good as conventional television production. Maxx Sports TV plans to reduce expenditures through a combination of proprietary processes, software and hardware.
Maxx Sports TV offers new ways for fans and teams to build and maintain emotional connection, for example, using Maxx Sports TV's proprietary "clone-of-a-clone" and "parallel-streams video technology to put game production tools in the hands of each and every Viewer.
" Maxx Sports TV has developed the ability to converge content and technology at a dramatically lower cost, making this new medium affordable and available to everyone," says Peter Luukko , Chairman of Maxx Sports TV .
Maxx Sports TV aims to develop full interactivity through the screen of every Viewer, as it is acquiring digital audio sports broadcasters and adding interactive video technology thereby converting a static Listener or Reader to an interactive Viewer.
About MAXX Sports TV
Maxx Sports TV is headquartered in Houston Texas , with historical US operations in Texas , Florida, Utah, Louisiana, and Nevada, with acquisitions and expansion planned for California, New York, New Jersey, and Illinois, with an aggregate of 200 million annual Users.
www.tsnsports.tv | www.maxxsports.tv | www.hockeylab.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/maxx-sports-tv-goes-public-301153603.html
SOURCE Maxx Sports TV, Inc.
0022
Tear down this wall!
chart looks beautiful...
https://stockcharts.com/h-sc/ui?s=ssok&p=D&yr=0&mn=6&dy=0&id=p00231052056
price breaking through the 50 day EMA resistance.
10 day EMA crossing the 20
once we bust through the 19/20 wall, and the 200 day EMA at 22, then BOOM!